APA (7th ed.) Citation

CS, M., AR, S., A, G., J, C., & F, F. (2018). CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors. BMC cancer, 18(1), 741. https://doi.org/10.1186/s12885-018-4650-9

Chicago Style (17th ed.) Citation

CS, Marques, Santos AR, Gameiro A, Correia J, and Ferreira F. "CXCR4 and Its Ligand CXCL12 Display Opposite Expression Profiles in Feline Mammary Metastatic Disease, with the Exception of HER2-overexpressing Tumors." BMC Cancer 18, no. 1 (2018): 741. https://doi.org/10.1186/s12885-018-4650-9.

MLA (9th ed.) Citation

CS, Marques, et al. "CXCR4 and Its Ligand CXCL12 Display Opposite Expression Profiles in Feline Mammary Metastatic Disease, with the Exception of HER2-overexpressing Tumors." BMC Cancer, vol. 18, no. 1, 2018, p. 741, https://doi.org/10.1186/s12885-018-4650-9.